
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="616CF74380956E6300F7430006D2DFAA.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="commschem">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Communications Chemistry">
<meta name="citation_title" content="Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs">
<meta name="citation_author" content="Álvaro Peña">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Juan Heredero">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Beatriz Blandín">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Elena Mata">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Diego De Miguel">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Alfonso Toro">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Teresa Alejo">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Diego Casabona">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Alexandre López">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Ana Gallego-Lleyda">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Esther Pérez-Herrán">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Juan Martínez-Oliván">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_author" content="Javier Giménez-Warren">
<meta name="citation_author_institution" content="Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain">
<meta name="citation_publication_date" content="2025 Apr 16">
<meta name="citation_volume" content="8">
<meta name="citation_firstpage" content="116">
<meta name="citation_doi" content="10.1038/s42004-025-01516-z">
<meta name="citation_pmid" content="40234552">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/pdf/42004_2025_Article_1516.pdf">
<meta name="description" content="Ionizable lipids are essential components of lipid nanoparticles (LNPs) for efficient mRNA delivery. However, designing them for high protein expression, endosomal escape, and organ targeting is challenging due to complex structure-activity ...">
<meta name="og:title" content="Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Ionizable lipids are essential components of lipid nanoparticles (LNPs) for efficient mRNA delivery. However, designing them for high protein expression, endosomal escape, and organ targeting is challenging due to complex structure-activity ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12000586">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s42004-025-01516-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/42004_2025_Article_1516.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000586%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12000586/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12000586/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-commschem.jpg" alt="Communications Chemistry logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Communications Chemistry" title="Link to Communications Chemistry" shape="default" href="https://www.nature.com/commschem/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Commun Chem</button></div>. 2025 Apr 16;8:116. doi: <a href="https://doi.org/10.1038/s42004-025-01516-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s42004-025-01516-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Commun%20Chem%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Commun%20Chem%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Commun%20Chem%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Commun%20Chem%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pe%C3%B1a%20%C3%81%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Álvaro Peña</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Álvaro Peña</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pe%C3%B1a%20%C3%81%22%5BAuthor%5D" class="usa-link"><span class="name western">Álvaro Peña</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heredero%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Juan Heredero</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Juan Heredero</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Heredero%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juan Heredero</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bland%C3%ADn%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Beatriz Blandín</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Beatriz Blandín</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bland%C3%ADn%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Beatriz Blandín</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mata%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Elena Mata</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Elena Mata</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mata%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elena Mata</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Miguel%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Diego De Miguel</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Diego De Miguel</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22De%20Miguel%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Diego De Miguel</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toro%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Alfonso Toro</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Alfonso Toro</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toro%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alfonso Toro</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alejo%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Teresa Alejo</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Teresa Alejo</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alejo%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Teresa Alejo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Casabona%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Diego Casabona</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Diego Casabona</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Casabona%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Diego Casabona</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%B3pez%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Alexandre López</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Alexandre López</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22L%C3%B3pez%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexandre López</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gallego-Lleyda%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Ana Gallego-Lleyda</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Ana Gallego-Lleyda</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gallego-Lleyda%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana Gallego-Lleyda</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22P%C3%A9rez-Herr%C3%A1n%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Esther Pérez-Herrán</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Esther Pérez-Herrán</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22P%C3%A9rez-Herr%C3%A1n%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Esther Pérez-Herrán</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mart%C3%ADnez-Oliv%C3%A1n%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Juan Martínez-Oliván</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Juan Martínez-Oliván</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mart%C3%ADnez-Oliv%C3%A1n%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juan Martínez-Oliván</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gim%C3%A9nez-Warren%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Javier Giménez-Warren</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Javier Giménez-Warren</span></h3>
<div class="p">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gim%C3%A9nez-Warren%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Javier Giménez-Warren</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Certest Pharma, Certest Biotec S. L., 50840 San Mateo de Gállego, Zaragoza, Spain</div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 15; Accepted 2025 Apr 4; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12000586  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40234552/" class="usa-link">40234552</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Ionizable lipids are essential components of lipid nanoparticles (LNPs) for efficient mRNA delivery. However, designing them for high protein expression, endosomal escape, and organ targeting is challenging due to complex structure-activity relationships. Here, we present a high-throughput platform for screening ionizable lipids using a two-step, scalable, one-pot reaction. This enabled the synthesis and <em>vivo</em> screening of 91 new lipids, followed by a structure-activity study, leading to the development of CP-LC-0729, which significantly surpasses the MC3 benchmark in protein expression with preliminary studies showing no in vivo toxicity. Additionally, a one-step strategy helped to yield a permanently cationic lipid which was tested in a fifth-lipid formulation, showing a highly selective lung delivery with a 32-fold increase in protein expression in vivo, outperforming current endogenous targeting strategies. All these findings underscore the potential of lipid CP-LC-0729 and our lipid platform in advancing the efficiency and specificity of mRNA delivery systems.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Lipids, Nanoparticles, Combinatorial libraries, Drug delivery, RNA</p></section></section><section class="abstract" id="Abs2"><hr class="headless">
<p id="Par2">Ionizable lipids are essential components of lipid nanoparticles (LNPs) for efficient mRNA delivery, however, efficiently optimizing their chemical structures remains challenging. Here, the authors report a high-throughput platform for screening ionizable lipids using a STAAR approach, allowing for the synthesis and in vivo screening of novel lipids followed by a structure-activity study, leading to the development of CP-LC-0729, which along with its counterpart is capable of targeting the lungs.</p></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">The interest in mRNA technology as a promising platform for the treatment of diverse pathologies, including cancer, has increased exponentially since the COVID-19 pandemic, when two mRNA vaccine candidates (i.e., mRNA-1273 and BNT162b) were authorized to tackle SARS-CoV-2. Indeed, mRNA-based technology has shown great potential in applications such as gene editing therapies, vaccines against infectious diseases and protein supplementation therapies<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>–<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a></sup>. In order to achieve protein expression in living organisms, mRNA molecules need a delivery platform to avoid nuclease degradation, promote cellular endocytosis and improve endosomal escape. Lipid nanoparticles (LNPs) demonstrate both advanced clinical status and effectiveness in overcoming delivery barriers for mRNA therapeutics, highlighting their importance as nonviral platforms<sup><a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>,<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>.</p>
<p id="Par4">LNPs commonly consist of mRNA, helper lipids (usually phospholipids), cholesterol, PEG-conjugated lipids and ionizable lipids<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. The role of ionizable lipids has been demonstrated as crucial in stabilizing and delivering mRNA<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. A fundamental chemical feature of ionizable lipids lies in the tertiary amino group which becomes charged in acidic pH but remains neutral at physiological conditions<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. During the formulation process at acidic pH, their positive charge aids in condensing the mRNA and, upon internalization, as the endosomes undergo acidic maturation, they assist in membrane disruption, facilitating endosomal escape. At physiological pH, ionizable lipids exhibit a neutral charge, resulting in reduced toxicity levels and enhanced biocompatibility<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. Two substantial research challenges currently being addressed involve understanding and improving the efficiency of LNPs’ endosomal escape (currently estimated to be around 2%) and achieving targeted in vivo delivery to specific cells or tissues for precision therapeutics<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>,<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>.</p>
<p id="Par5">Despite the extensive research and advances into ionizable lipid development, ionizable lipids typically consist of distinct common structural components: an ionizable headgroup and at least two hydrophobic alkyl tails tethered together through a linker, often containing degradable bonds such as esters. Ester bonds have been chosen for their ability to break down in vivo thanks to the activity of esterases, which improves their biocompatibility<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. Moreover, ionizable lipids commonly include at least two hydrophobic tails, which can foster a cone-like shape, improving endosomal escape and mRNA delivery by promoting the formation of inverted hexagonal phases<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. Adjusting the bonds and chemical structures in ionizable lipids to achieve effective and safe in vivo delivery has sparked interest recently. However, three significant challenges persist regarding ionizable lipid design and synthesis: Firstly, despite some general characteristics previously outlined, precise structural design rules are still lacking regarding the relationship between their structural features and in vivo delivery<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. Moreover, major bottlenecks in mRNA delivery, such as endosomal escape, could be addressed by gaining a better understanding of structure-activity relationships<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Indeed, the most recurrent approach to novel ionizable lipid development is to conduct massive screenings of synthetic candidates based on combinatorial chemistry to identify those that are particularly effective in drug delivery<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>–<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>.</p>
<p id="Par6">Secondly, addressing the necessity for screening lipid candidates requires avoiding multi-step and complicated synthetic protocols, highlighting the importance of rapid and cost-effective synthetic strategies<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>,<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. Numerous strategies have been explored so far, for example, aza-Michael addition with acrylates, ester formation, and epoxide opening<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>. However, obtaining the necessary building blocks typically involves several time-consuming syntheses, harsh conditions and purification steps, which can hinder structural optimization and once again the understanding of structure-activity relationships<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>.</p>
<p id="Par7">Thirdly, there is a growing interest in developing LNPs that can target certain tissues or organs through passive targeting<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. In this sense, one of the most successful strategies up to date is the inclusion of a fifth lipid in the composition of the LNPs. Siegwart and coworkers developed formulations by incorporating either cationic or anionic lipids, thereby enabling targeted delivery to the lungs or spleen, respectively<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>.</p>
<p id="Par8">Here, we developed a rapid, high-throughput and cost-effective platform for screening ionizable lipids. We utilized a versatile multidimensional synthesis approach involving mild conditions and two tandem one-pot reactions: thiolactone ring opening and Michael addition. We then investigated the structure-activity relationships of hydrophobic tails and functional groups leading to the best ionizable lipid candidate. Finally, the combination of this candidate, CP-LC-0729, with a permanently cationic lipid, which can be accessed via a single synthetic step, demonstrated a very high selectivity to lungs with a remarkable 32-fold increase in protein expression compared to the benchmark. Altogether, these results highlight the potential of the STAAR platform (standing for Sequential Thiolactone Amine Acrylate Reaction) in generating new promising lipid candidates for both hepatic and extrahepatic therapeutic applications.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results and discussion</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Sequential Thiolactone Amine Acrylate Reaction (STAAR lipids)</h3>
<p id="Par9">Similarly to other ionizable lipid structures, STAAR lipids consist of a polar head, a linker, and hydrophobic tails. Given that one of the aims of this study was precisely to examine how the various fragments of these lipids can influence their in vivo performance, a combinatorial chemistry approach was followed to screen a selection of lipids that included different moieties in their structure. For simplicity, each lipid was named as AiBjCk to account for the reagents used for their synthesis. In this nomenclature, Ai represents an amine (polar head); Bj indicates the linker, which consists of a thiolactone incorporating a hydrophobic tail, and Ck represents an acrylate with another hydrophobic tail.</p>
<p id="Par10">The synthetic process of STAAR lipids is illustrated in Fig. <a href="#Fig1" class="usa-link">1a</a>. Briefly, this two-step synthesis starts with the coupling of homocysteine thiolactone with a carboxylic acid to yield the corresponding linker intermediate (Bj). The second step involves a tricomponent one-pot sequential reaction which starts with a ring-opening addition of the intermediate (Bj) with an amine (Ai) followed by a Michael addition with an acrylate (Ck) to yield the lipid AiBjCk<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. Remarkably, this multicomponent reaction can be carried out at room temperature, without need for catalysts or inert atmosphere, and within a 2-h reaction time. Moreover, the high purity (&gt;80%) obtained makes it an optimal method for the rapid multidimensional screening of ionizable lipids, eliminating the need for further purification steps. This method simplifies the synthesis of new ionizable lipids in 1.5 mL tubes, reducing the reliance on expert organic synthesis knowledge, which allowed the rapid screening of nearly 100 novel lipids.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Design and synthesis scheme of STAAR ionizable lipids.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000586_42004_2025_1516_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ff/12000586/f8c955fa2479/42004_2025_1516_Fig1_HTML.jpg" loading="lazy" id="d33e359" height="523" width="800" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Representative scheme describing STAAR lipids synthetic steps. First, the synthesis of Bj thiolactone derivative and then the one-pot tricomponent reaction. The amine opens the thiolactone ring of Bj (aminolysis) and subsequently the thiol group reacts with the acrylate to afford the final lipid with high purity in short times and at room temperature<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>. <strong>b</strong> Scheme of the process followed for the formulation of lipids into LNPs for mRNA delivery in vivo.</p></figcaption></figure><p id="Par11">The general structure of the resulting STAAR lipids includes two amide bonds (one originating from the reaction of the amine Ai and the thiolactone Bj and the other one connecting this thiolactone to its hydrophobic tail), a thioether bond (from Bj), and an ester group (from Ck). Consequently, any changes to be made in the hydrophobic tails can be achieved by modifying the structure of the thiolactone derivatives (Bj) and acrylates (Ck).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Two-phase screening strategy for ionizable lipids</h3>
<p id="Par12">To assess how different moieties affect the final structure and activity of the lipid, a two-phase screening strategy was devised in which one component of the lipid (Ai, Bj, or Ck) was initially kept constant while the other two were varied. This method enabled us to systematically evaluate the impact of each component on the lipid’s performance. By fixing one fragment and varying the other two, the intention was to efficiently identify the most promising candidates, thereby streamlining the screening process and optimizing our approach. Thus, the screening process was divided into two optimization phases, with each phase focusing on the optimization of a different lipid moiety (Fig. <a href="#Fig2" class="usa-link">2</a>a, <a href="#Fig2" class="usa-link">b</a>). This methodological approach not only reduced the number of required experimental animals but also enhanced the efficiency of the screening process.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Screening optimization of STAAR lipids.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000586_42004_2025_1516_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ff/12000586/9b7e4720281d/42004_2025_1516_Fig2_HTML.jpg" loading="lazy" id="d33e397" height="1000" width="774" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Amines (Ai), Bj derivatives and acrylates (Ck) used for lipid screening. <strong>b</strong> Scheme summarizing the strategy followed for the two screening phases. <strong>c</strong> Total flux (entire mouse body) results of screening phase 1, where B was optimized by combining different acrylates and Bj derivatives while keeping polar head (A1) fixed. Mice were intramuscularly injected (i.m.) with mRNA-Luc-loaded LNPs at an mRNA dose of 0.05 mg/kg. Luminescence imaging acquisition was performed at 4 h post-treatment and total flux was quantified. In vivo mLuc expression displayed in a heat map (<em>n</em> = 3 biologically independent samples). Data are presented as mean values. <strong>d</strong> Total flux results table of Screening phase 2 where A and C were optimized by combining different amines and acrylates while keeping B2 fixed. Mice were i.m injected with mRNA-Luc-loaded LNPs at an mRNA dose of 0.05 mg/kg. Total flux luminescence imaging acquisition of the whole mouse body was performed at 4 h post-treatment and total flux was quantified. In vivo mLuc expression displayed in a heat map (<em>n</em> = 3 biologically independent samples). Data are presented as mean values. Below each table, representative luminescence images of each lipid in mice acquired using the IVIS Lumina XRMS Imaging System are shown.</p></figcaption></figure><p id="Par13">For this optimization phase, the effectiveness of each IL candidate was evaluated by formulating each lipid individually into LNPs using a pipette rapid mixing procedure<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. Thus, each LNP was composed of an ionizable lipid (AiBjCk), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), cholesterol, and 1,2-dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (DMG-PEG-2000) (50:10:38.5:1.5 molar ratios, respectively) and firefly luciferase mRNA (with a 6:1 molar N/P ratio Fig. <a href="#Fig1" class="usa-link">1b</a>),we selected the same molar lipid ratios used for FDA-approved siRNA drug (Onpattro) and FDA-approved mRNA vaccine (mRNA-1273)<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>.</p>
<p id="Par14">Also, due to the weak correlation between in vitro and in vivo LNP performance<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>, a direct screening in vivo using mice as animal model was followed, for which a firefly luciferase mRNA dose of 0.05 mg/kg was administered intramuscularly (i.m.) and the luminescence results were measured at 4 h post-inoculation.</p>
<section id="Sec5"><h4 class="pmc_sec_title">Screening phase 1: optimization of linker’s hydrophobic chain (Bj)</h4>
<p id="Par15">The first phase of the structure optimization, aimed to select the optimal Bj component by synthesizing 21 lipids in which the polar head was fixed (A1 was selected) while combining three types of thiolactones with different acrylates (Fig. <a href="#Fig2" class="usa-link">2c</a>). This amine was chosen as its structure closely resembles that of the MC3 polar head, featuring a spacer of three methylene units between a tertiary amine and a carbonyl group<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. The hydrophobic chains linked to the thiolactone derivatives (Bj) were selected to have distinctly different structures: a linear chain (B1) with 18 carbon atoms, an unsaturated chain (B2), and a branched chain (B3).</p>
<p id="Par16">The analysis of the protein expression (Fig. <a href="#Fig2" class="usa-link">2c</a>) achieved for the LNPs for each individual lipid revealed that A1B2Ck lipids (with k ranging from 1 to 7) resulted in increased protein expression for in vivo mRNA delivery, regardless of the acrylate used (Ck). This observation aligns with existing literature, which suggests that branched structures often confer enhanced performance in lipid-based delivery systems<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. Moreover, unsaturated chains yielded higher expression than saturated ones. Notably, hydrophobic moieties C3 and C7 were particularly effective.</p></section><section id="Sec6"><h4 class="pmc_sec_title">Screening phase 2: optimization of polar head (Ai) and second hydrophobic chain (Ck)</h4>
<p id="Par17">Based on the findings from the screening phase 1, B2 was selected as the foundation for the next screening step. This second phase aimed to optimize the other two moieties of the molecule: the polar head (Ai) and the second hydrophobic chain (derived from Ck). Once again, the use of the STAAR synthesis approach for this optimization process allowed for a swift exploration of these structural moieties thanks to the high purities achieved in the sequential reactions used in their synthesis. More specifically, 70 AiB2Ck novel lipids were synthesized, with i and k ranging from 2 to 11 and 1 to 7, respectively (Fig. <a href="#Fig2" class="usa-link">2d</a>).</p>
<p id="Par18">Moreover, LNPs commonly consist of mRNA, help a comparative assay between crude and purified ionizable lipid to assess its impact on protein expression (Fig. <a href="#MOESM2" class="usa-link">S3</a>). The results demonstrated no significant differences in performance between the two forms, thus validating the reliability of our approach. This result provides reassurance that the structure-function relationships derived from our screening data using crude lipids are reliable and directly translatable to purified compounds.</p>
<p id="Par19">Regarding the Ai moiety, diverse polar heads, including cyclic, linear, aromatic, and analogs with a variable number of ionizable N groups, underwent testing. Upon in vivo evaluation, cyclic and aromatic amines (A5, A6, A7, A8, A9) failed to demonstrate significant expression, the only exception being that of A11. In contrast, among the linear amines, A2 and A4 displayed the best results, with lipid A4B2C3 notably yielding the highest expression levels. Remarkably, the comparison of amines A1 and A4, which differ by just one single methylene unit, resulted in an almost 5-fold increase in expression for lipid A4B2C3 over A1B2C3, emphasizing the role of the number of methylenes between the tertiary amine and the primary amine of Ai in the lipid performance. These observations showcase the sensitivity of lipid performance to minor structural changes in the spacer length of the polar head. Remarkably, the comparison of amines A1 and A4, which differ by just one single methylene unit, resulted in an almost 5-fold increase in expression for lipid A4B2C3 over A1B2C3, emphasizing the role of the number of methylenes between the tertiary amine and the primary amine of Ai in the lipid performance<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. These observations showcase the sensitivity of lipid performance to minor structural changes in the spacer length of the polar head performance<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. These observations showcase the sensitivity of lipid performance to minor structural changes in the spacer length of the polar head.</p>
<p id="Par20">With regards to the hydrophobic tails (stemming from Ck), we confirmed the previously observed trend for Bj, with the 2-butyl-1-octanol derived branched acrylate (C3) yielding the lipids with highest expression levels. Additionally, linear 18-carbon monounsaturated (C1) also showed promising results in vivo. We also noticed that when shorter acrylate chains were used, the in vivo expression decreased up to 60 times, irrespective of it being branched or linear, this including isooctyl (C7), ethylhexyl (C2), and linear octyl (C6). Moreover, intermediate length chains (C5 and C4, 12 and 14 carbons in length, respectively), led to higher expression compared to shorter chains, yet the expression remained three times lower than C3 and C1. This suggests that longer chains, featuring unsaturations or branches in the hydrophobic moiety Ck, might be necessary to achieve the desired electronic and steric balance in the STAAR lipids.</p>
<p id="Par21">Altogether, this screening phase highlighted the profound impact of the C moiety, where branched and unsaturated Ck chains, especially C3, demonstrated substantial improvements in protein expression.</p>
<p id="Par22">In relation to physicochemical parameters of LNPs, observed sizes ranged from 150 to 230 nm, with the majority falling beneath 190 nm. Polydispersity indexes mostly lay below 0.25, while ζ potentials ranged between 5 mV and −25 mV, with all lipids but four exhibiting a negative ζ potential. mRNA encapsulation rates varied from 20% to 100% (Table <a href="#MOESM2" class="usa-link">S2</a>). Notably, lipids with higher activity achieved encapsulation rates between 60% and 80% (with a direct pipetting method), hence suggesting this might represent the optimal encapsulation range for STAAR lipids LNPs in the screening phase. Moreover, we noted that even though employing an amine featuring two ionizable groups (A5) as lipid head results in high encapsulation rate, this does not reflect in its performance, as the in vivo activity was found to be 2 to 30 times lower compared to lipids containing amine A4, which contains only one ionizable group.</p>
<p id="Par23">As expected, in terms of biodistribution, all intramuscular injections primarily displayed fluorescence signals concentrated in the muscle area of administration. This is consistent with previously reported findings, where mRNA-containing LNPs administered intramuscularly tend to express at the injection site and to some extent, in the liver<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup> (Fig. <a href="#Fig2" class="usa-link">2</a>c, <a href="#Fig2" class="usa-link">d</a>).</p></section></section><section id="Sec7"><h3 class="pmc_sec_title">Fine-tuning of the ionizable lipid structure</h3>
<p id="Par24">Following the discovery of lipid A4B2C3 as the top-performing candidate in the initial two-phase screening approach, the research focused on exploring the impact of further modifications to the lipid structure, specifically targeting the hydrophobic branched chains.</p>
<p id="Par25">After identifying A4B2C3 as the most effective ionizable lipid in the two-phase screening, further structural studies were conducted to assess the impact of hydrophobic chain lengths and functional groups and their roles in influencing lipid performance. The purpose of this stage was to deepen the understanding of how variations in the chemical structure can influence protein expression, thereby refining the structure-activity relationship for improved delivery efficiency.</p>
<section id="Sec8"><h4 class="pmc_sec_title">Assessment of the hydrophobic tails of lipid A4B2C3</h4>
<p id="Par26">Following the same synthetic approach as in the screening phase, we synthesized and purified eight additional ionizable lipids, hence introducing three distinct branched chain lengths via the Bj and Ck moieties (Fig. <a href="#Fig3" class="usa-link">3a</a>). Having optimized the lipid structure in the initial phases, for these refining phases we relied on microfluidic techniques to confirm the previous conclusions while keeping the formulation process precisely controlled. Nanoparticles were obtained with sizes ranging from 80 to 130 nm, with the majority being under 100 nm, and they exhibited high encapsulation efficiencies (90–99%, Table <a href="#MOESM2" class="usa-link">S4</a>). Thus, a purified batch of the optimized lipid A4B2C3 along with these new 8 lipids were formulated into LNPs along with three separate controls. Two out of three controls used MC3 as ionizable lipid in the same molar and N/P ratios as the screened lipids, one of them included DOPE as helper lipid (same as the formulated STAAR lipids), namely MC3 DOPE, whereas the other one replicated the MC3 LNP benchmark by using DSPC. We also added SM-102 used for FDA-approved mRNA vaccine as control. Remarkably, when comparing the in vivo results to those of the MC3 benchmark LNP<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup> (Table <a href="#MOESM2" class="usa-link">S3</a>), eight out of the nine tested lipids showed a total flux that was at least double that of the MC3 benchmark.</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3. Assessment of the hydrophobic tails of A4B2C3 and structure-activity relationships in STAAR lipids.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000586_42004_2025_1516_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ff/12000586/e36474e50e6c/42004_2025_1516_Fig3_HTML.jpg" loading="lazy" id="d33e551" height="999" width="721" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Building blocks for hydrophobic tail optimization, combining A4, branched Bj derivatives and branched acrylates. <strong>b</strong> In vivo luminescence total flux results of <strong>a</strong> structures normalized respect to MC3 benchmark LNP, with the dashed line in the <em>y</em>-axis representing the results of control MC3 benchmark LNP. MC3(DOPE) LNP was also used as control employing DOPE as helper lipid. Mice were i.m injected with mRNA-Luc-loaded LNPs at an mRNA dose of 0.05 mg/kg. Luminescence imaging acquisition was performed at 4 h post-treatment and total flux was quantified. In vivo mLuc expression (<em>n</em> = 3 biologically independent samples). Data are presented as mean values ± standard deviation (SD). <strong>c</strong> Schematic lipids set structure displaying different functional groups varying in alpha (α) and beta (β) positions. <strong>d</strong> Results of lipids in <strong>c</strong>, in vivo mLuc expression (<em>n</em> = 3 biologically independent samples). Data are presented as mean values ± SD. Mice were i.m injected with mRNA-Luc-loaded LNPs at an mRNA dose of 0.05 mg/kg. Luminescence imaging acquisition was performed at 4 h post-treatment and total flux was quantified. <strong>e</strong> ζ potentials and pKa of the formulated LNPs (<em>n</em> = 3 biologically independent samples). Data are presented as mean values. In <strong>b</strong> and <strong>d</strong> one-way ANOVA with Tukey’s correction was used.</p></figcaption></figure><p id="Par27">Among these, the result for A4B2C8 (known as CP-LC-0729) was particularly striking (Fig. <a href="#MOESM2" class="usa-link">S4</a>), as it demonstrated an expression value 6.4 times higher than the MC3 benchmark control. Furthermore, it outperformed SM-102 control (Fig. <a href="#Fig3" class="usa-link">3b</a>), which firmly establishes this lipid as the best candidate for further studies and optimization. The exception amongst these 8 lipids was observed with lipid A4B4C3, characterized by the shortest hydrophobic chain combination, and for which the expression dropped to 0.034 times relative to the MC3 benchmark. The results suggest that a tail with a minimum carbon number may be necessary for achieving high protein expression, aligning with the trend observed during the two-phase screening, where shorter chains such as C2, C6, and C7 consistently resulted in lower protein levels<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>.</p></section><section id="Sec9"><h4 class="pmc_sec_title">Influence of functional groups in the structure-activity relationship of STAAR lipids</h4>
<p id="Par28">After exploring the impact of altering the hydrophobic chains and identifying lipid CP-LC-0729, which contains two branched chains (B2, C8), as the best candidate for high-performing in vivo activity, our focus then shifted to study the functional groups within the structure. As previously reported in literature, certain bonds, such as esters, play a pivotal role in endosomal escape and degradation pathways<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>,<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. Taking advantage of the chemical versatility of STAAR lipids, which allows for modular modification of functional groups, we investigated how the nature of specific bonds can influence the performance of the STAAR lipids.</p>
<p id="Par29">We focused specifically on the role of the amide bonds, which are common to all previously synthesized STAAR lipids and are located at positions referred to as α and β<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>, by synthesizing purified structural variations of CP-LC-0729 as depicted in Fig. <a href="#Fig3" class="usa-link">3c</a>. These products were subsequently formulated with the same N/P and lipid ratios used in the initial screenings, employing microfluidic mixing.</p>
<p id="Par30">As a first step, we inverted the C-N carbonyl order (N-CO to CO-N) of the β amide bond (CP-LC-0729-03) resulting in a threefold reduction of in vivo protein expression compared to CP-LC-0729 (Fig. <a href="#Fig3" class="usa-link">3</a>c, <a href="#Fig3" class="usa-link">d</a>). This change may be attributed to the shift in the relative position of the β amide hydrogen bond, which can potentially affect the intermolecular force landscape and packing of the molecule<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>.</p>
<p id="Par31">Then, to further explore the role of the α amide bond, lipid CP-LC-0729-02 was synthesized, where the α amide is methylated, resulting in a 3.4-fold decrease of in vivo expression. In the next step, the amide bonds were partially or completely substituted with ester bonds in CP-LC-0729-01, CP-LC-0729-04 and CP-LC-0729-05. In this case, we noticed a significant decrease in effectiveness—by two orders of magnitude—when replacing both amides (α and β positions) with ester groups in CP-LC-0729-05 (Fig. <a href="#Fig3" class="usa-link">3d</a>). This change resulted in the lowest performance among the proposed variations, and contrasts with the fact that other commercial ionizable lipids such as ALC-0315, SM-102, or MC3 only feature ester groups. As a middle-ground case, when combining an amide and an ester group, the in vivo performance was dependent on relative position of the groups, yielding intermediate outcomes. Interestingly, when lipids contain only one amide, their expression is four and a half times higher when located in the α position (CP-LC-0729-04) compared to the β position (CP-LC-0729-01). Thus, these results indicated that preserving the α amide bond (CP-LC-0729-04) led to better expression results than replacing it with an ester group (CP-LC-0729-05). Remarkably, the protein expression value of the methylated α amide lipid CP-LC-0729-02 was on par with CP-LC-0729-03 and CP-LC-0729-04. Interestingly, when lipids contain only one amide, their expression is four and a half times higher when located in the α position (CP-LC-0729-04) compared to the β position (CP-LC-0729-01). Additionally, in the case of the methylated α amide (CP-LC-0729-02), which no longer acts as a hydrogen bond donor, the expression decreased threefold compared to the non-methylated counterpart, suggesting that hydrogen bonds might play a key role. We hypothesize that the observed difference may arise from the α amide proximity to the polar head, potentially enhancing the pKa and its availability to interact with mRNA via hydrogen bonding or intermolecular interactions between ionizable lipids. The optimal combination, as evidenced by our findings, involves amides located at both the α and β sites, reflecting in the chemical structure of lipid CP-LC-0729.</p>
<p id="Par32">Regarding the LNP physicochemical characterization, we noticed that altering the α amide bond led to lower LNP pKa. Specifically, pKa values were the lowest for CP-LC-0729-05 (pKa = 5.48) and CP-LC-0729-01 (pKa = 6.12). A similar trend was observed when measuring ζ potential, as CP-LC-0729-05 (ζ = −18.0 mV) and CP-LC-0729-01 (ζ = −10.3 mV) displayed the lowest values of the series (Fig. <a href="#Fig3" class="usa-link">3e</a>).</p>
<p id="Par33">Additionally, to further evaluate the behavior of lipid CP-LC-0729 in different formulations, an in vivo study using LNPs with different molar ratios of the four lipid components was conducted. The results, detailed in Table <a href="#MOESM2" class="usa-link">S7</a>, indicate that CP-LC-0729 performs well even when the molar ratios diverge from the ones used in more conventional formulations, highlighting its versatility. We also characterized CP-LC-0729 LNP using the same formulation used in screening process through cryo-TEM to evaluate the structure and morphology. CP-LC-0729 LNP displayed a spherical shape with uniform size and solid-core morphology, with some bleb structures (Fig. <a href="#Fig4" class="usa-link">4a</a>). Previous studies have documented the presence of bleb structures in LNPs. These structures are reported to improve the stability of the mRNA cargo and transfection efficiency in both in vivo and in vitro<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>.</p>
<figure class="fig xbox font-sm" id="Fig4"><h5 class="obj_head">Fig. 4. In vivo safety and cell internalization profile of CP-LC-0729 LNP.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000586_42004_2025_1516_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ff/12000586/cc0d6d55c709/42004_2025_1516_Fig4_HTML.jpg" loading="lazy" id="d33e662" height="378" width="800" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Representative cryo-TEM images of CP-LC-0729 LNP. Scale bar, 100 nm. <strong>b</strong> Serum alanine aminotransferase levels (ALT), serum aspartate aminotransferase levels (AST), serum alkaline phosphatase levels (ALP), urea nitrogen concentration (UREA). Mice were intravenously injected (i.v) with mRNA-Luc-loaded LNPs at an mRNA dose of 2.5 mg/kg (<em>n</em> = 5 biologically independent samples). Serum was collected for ALT, AST, ALP and UREA analysis at 24 h and 48 h post-treatment. Data are presented as mean values ± SD. Two-way ANOVA with Tukey’s correction was used. <strong>c</strong> Body weight change for 15 days (measured made at days 0, 1, 2, 7, 9, 13 and 15). Mice were i.v injected with mRNA-Luc-loaded LNPs at an mRNA dose of 2.5 mg/kg (<em>n</em> = 5 biologically independent samples). Data are presented as mean values ± SD. <strong>d</strong> Uptake inhibition of CP-LC-0729 and MC3(DOPE) LNP by different endocytosis inhibitors (<em>n</em> = 3 biologically independent samples). The inhibitors used were Amiloride (inhibitor of macropinocytosis), Chlorpromazine (inhibitor of clathrin-mediated endocytosis), Genistein (inhibitor of caveolae mediated endocytosis), Methyl-β-cyclodextrin (inhibitor of lipid raft mediated endocytosis). Data are presented as mean values ± SD. <strong>e</strong> Hemolysis assay of CP-LC-0729 LNP and MC3(DOPE) LNP at pH 7.4 or 6.0. RBCs were incubated with CP-LC-0729 LNP and MC3(DOPE) LNP at an mRNA concentration of 2.5 μg/mL at 37 °C for 1 h. Positive and negative controls were carried out with 0.1% Triton-X and 1× PBS, respectively. Data are presented as mean ± SD (<em>n</em> = 3 biologically independent samples).</p></figcaption></figure></section></section><section id="Sec10"><h3 class="pmc_sec_title">Additional biological assays of the top-performing ionizable lipid CP-LC-0729 LNP</h3>
<section id="Sec11"><h4 class="pmc_sec_title">In vivo safety profile of lipid CP-LC-0729</h4>
<p id="Par34">After selecting CP-LC-0729 as the best performing ionizable lipid candidate through the in vivo screening and subsequent optimization phases, different biological assays were carried out to evaluate the safety profile. Thus, in vivo toxicity assays on CP-LC-0729 LNPs were conducted to assess any potential organ damage by measuring liver enzymes (ALT, AST, ALP) and kidney function (UREA) at 24 and 48 h after systemic injection at a high dose (2.5 mg/kg). When compared to the PBS buffer used as a control, CP-LC-0729 LNPs showed no significant impact on the levels of these enzymes (Fig. <a href="#Fig4" class="usa-link">4b</a>). The change in mice body weight was monitored for 15 days post-inoculation, revealing no apparent differences compared to the negative control (PBS buffer) (Fig. <a href="#Fig4" class="usa-link">4c</a>). In order to further assess the intramuscular toxicity of CP-LC-0729, we examined the muscular area surrounding the inoculation site for signs of toxicity by comparing TRIS buffer, CP-LC-0729, and SM-102; no apparent signs of toxicity were observed (Fig. <a href="#MOESM2" class="usa-link">S9</a>). While a more comprehensive assessment, including testing across different animal models, is necessary to establish a complete safety profile of this lipid, our preliminary results indicate excellent tolerability following systemic administration, with no signs of toxicity observed under the conditions studied.</p></section><section id="Sec12"><h4 class="pmc_sec_title">Evaluation of cell internalization of CP-LC-0729 LNPs</h4>
<p id="Par35">To gain deeper insights into the mechanisms of cell internalization, the endocytosis pathways of CP-LC-0729 LNP were examined in vitro in hepatic HepG2 cells. Four endocytic pathways were assessed by incubating the LNPs with specific inhibitors for each route before in vitro transfection<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. The results show that the uptake of CP-LC-0729 LNPs strongly relies on lipid rafts, as indicated by inhibition with methyl-β-cyclodextrin. Other internalization pathways, such as macropinocytosis and clathrin-mediated endocytosis, showed a smaller contribution. Additionally, genistein did not inhibit uptake, indicating that caveolae-mediated endocytosis is not significant (Fig. <a href="#Fig4" class="usa-link">4d</a>). We also conducted hemolysis assays to assess endosomal escape of CP-LC-0729 LNPs through their membrane-disrupting activity under both acidic (pH 6) and physiological (pH 7.4) conditions<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>,<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. These tests showed that CP-LC-0729 LNPs increased hemolysis in the acidic medium up to 90%, ten times higher than the MC3 (DOPE) LNP used as control. In contrast, at physiological pH, the hemolytic activity remained comparable to the control level (PBS) indicating no hemotoxicity (Fig. <a href="#Fig4" class="usa-link">4e</a>). This suggests a potential enhanced endosomal escape mechanism of CP-LC-0729 LNPs at acidic pH, while maintaining hemocompatibility at physiological conditions, a result that is in accordance with the fact that lipid CP-LC-0729 shows a higher in vivo performance than MC3 while displaying no signs of toxicity<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>.</p></section></section><section id="Sec13"><h3 class="pmc_sec_title">Extrahepatic organ targeting of CP-LC-0729 using permanently cationic lipids</h3>
<p id="Par36">Recognizing the critical importance of targeting specific organs for effective therapeutic outcomes, we focused on achieving extrahepatic mRNA delivery to broaden the scope and versatility of ionizable lipid CP-LC-0729 and the STAAR screening platform. As reported by Siegwart and coworkers<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>,<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>, the addition of a fifth permanently charged lipid results in selective targeting of the lungs or spleen, attributed to changes in the protein corona and LNP surface charge<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. Herein we explored a streamlined approach to modify the STAAR ionizable lipid CP-LC-0729 into its permanently cationic form (+) CP-LC-0729, using a single synthetic step, and later carried out a comparative study with what is reported in the literature following the fifth-lipid strategy. Hence, a novel cationic lipid was synthesized, denoted as (+) CP-LC-0729, as it is derived from the methylation of the tertiary amine of the top-performing ionizable lipid CP-LC-0729 (Fig. <a href="#Fig5" class="usa-link">5a</a>). Subsequently, the performance of ionizable lipids MC3 and CP-LC-0729 was compared, in LNPs incorporating cationic lipids (+) CP-LC-0729 or the standard commercial alternative DOTAP as fifth lipids, using representative formulations with firefly luciferase mRNA (Fig. <a href="#Fig5" class="usa-link">5b</a>)<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. As shown in Table <a href="#MOESM2" class="usa-link">S5</a>, the cationic lipid molar percentages were compared using LNPs that incorporated different proportions of this fifth lipid (30%, 40% and 50% (mol/mol)). The experiments were conducted using microfluidics mixing for LNPs, followed by intravenous administration. LNPs were termed as [cationic lipid (percentage of cationic lipid in molar rate) ionizable lipid] LNP, for example, LNP using DOTAP as cationic lipid at 50% combined with MC3 as ionizable lipid was designated [DOTAP (50%) MC3] LNP.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Lung targeting strategy using a STAAR permanently cationic lipid.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000586_42004_2025_1516_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68ff/12000586/2e8d04212b31/42004_2025_1516_Fig5_HTML.jpg" loading="lazy" id="d33e754" height="535" width="800" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Synthetic scheme used to prepare a permanent cationic lipid, namely (+) CP-LC-0729, from an ionizable lipid CP-LC-0729. <strong>b</strong> Schematic representation of the formulated LNPs incorporating a STAAR permanently cationic lipid as fifth component for mRNA delivery in vivo through i.v. administration. <strong>c</strong> Top to bottom: Ex vivo luminescence of major organs from mice, pie charts showing a profile of the tissue-specificity of mLuc expression in the lungs, heart, liver, intestine, spleen and kidneys, bar representation of total luminescence found in lungs and table with the formulation details of LNPs (<em>n</em> = 3 biologically independent samples). Mice were i.v. injected with mRNA-Luc-loaded LNPs at an mRNA dose of 0.2 mg/kg. Images were acquired at 4 h post-treatment. For the bar graph, data are presented as mean values ± SD. One-way ANOVA with Tukey’s correction was used.</p></figcaption></figure><p id="Par37">Regarding the physiochemical properties, LNPs with (+) CP-LC-0729 showed similar values to CP-LC-0729 LNP, including particle size (60–85 nm) and 99% mRNA encapsulation efficiency. However, we noticed positive surface ζ potentials in (+) CP-LC-0729 LNPs, which varied depending on the cationic lipid ratio used (Table <a href="#MOESM2" class="usa-link">S6</a>).</p>
<p id="Par38">After inoculation, ex vivo assays revealed distinct variations in protein expression in the lungs, depending on the cationic lipid ratio. The [(+) CP-LC-0729 (50%) CP-LC-0729] lipid nanoparticles (LNPs) demonstrated remarkable selectivity for the lungs, achieving 88% selectivity. Even the [(+) CP-LC-0729 (40%) CP-LC-0729] and [(+) CP-LC-0729 (30%) CP-LC-0729] LNP exhibited strong selectivity, 88% and 82%, respectively (Figs. <a href="#MOESM2" class="usa-link">S5</a> and <a href="#MOESM2" class="usa-link">S6</a>), far exceeding the 38% selectivity observed for the benchmark LNP, [DOTAP (50%) MC3].</p>
<p id="Par39">Moreover, when [(+) CP-LC-0729] was formulated with MC3, the resulting expression levels were twofold lower than when it was combined with CP-LC-0729 (Fig. <a href="#Fig5" class="usa-link">5c</a>). Even more remarkably is the fact [(+) CP-LC-0729 (50%) CP-LC-0729] LNP exhibited 32-fold higher luciferase expression compared to the benchmark [DOTAP (50%) MC3] LNP (Fig. <a href="#Fig5" class="usa-link">5c</a>). These findings demonstrate that both the selectivity and protein expression of CP-LC-0729 combinations significantly outperform the benchmark [DOTAP (50%) MC3] formulation. Furthermore, the optimal results observed when combining (+) CP-LC-0729 with CP-LC-0729 may suggest that structural similarity between the ionizable and cationic forms may improve lipid packing and enhance overall LNP performance. In order to broaden the scope of our approach, we synthesized and conducted in vivo assessments of two additional cationic lipids, (+) A4B2C1 and (+) A2B2C4, using the same one-pot strategy and ionizable lipid CP-LC-0729. Interestingly, the resulting LNPs also exhibited tropism to the lungs, with selectivity values of 66% and 59%, respectively. Notably, the total flux observed in the lungs was significantly higher for (+) A4B2C1 compared to (+) A2B2C4, which was consistent with the enhanced mRNA delivery performance observed for A4B2C1 in the phase 2 screening (Fig. <a href="#MOESM2" class="usa-link">S8</a>). Overall, [(+) CP-LC-0729 (50%) CP-LC-0729] LNPs remained the most effective formulation for lung delivery (Fig. <a href="#MOESM2" class="usa-link">S7</a>). These results show the potential of CP-LC-0729, while also expanding its application to therapies requiring targeted extrahepatic delivery.</p>
<p id="Par40">Additionally, [(+) CP-LC-0729 (50%) CP-LC-0729] LNP was formulated with a small percentage of the fluorescent probe DiR (dialkylcarbocyanine, 1,1’-dioctadecyl-3,3,3’,3’-tetramethylindotricarbocyanine iodide) to track fluorescence and determine LNP biodistribution. While most LNPs were directed to the liver, luciferase expression was observed predominantly in the lungs (Fig. <a href="#MOESM2" class="usa-link">S8</a>).</p></section></section><section id="Sec14"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par41">The STAAR platform enables the synthesis of ionizable lipids in a high-throughput, one-pot setup, offering cost-efficiency, modular structure design and mild reaction conditions with shortened times which can easily be scaled up. Through the combinatorial synthesis and in vivo screening of 91 molecules, we identified several effective STAAR lipid candidates during two optimization phases. We then explored key structural characteristics governing their activity through structure-activity relationship studies, including hydrophobic tails and functional groups, identifying lipid CP-LC-0729 as the top-performing candidate and laying the groundwork for discovering new effective STAAR lipids in the future. Compared to the benchmark MC3, ionizable lipid CP-LC-0729 exhibited 6.4 times higher protein expression and showed no preliminary signs of in vivo toxicity, positioning it as a promising, readily scalable candidate for clinical advancement. We further validated the efficacy of the STAAR platform by introducing a one-step strategy for developing cationic lipids. The use of lipid CP-LC-0729, in combination with its permanently cationic counterpart, produced lipid nanoparticles (LNPs) that achieved a remarkable 32-fold increase in lung protein expression compared to the benchmark SORT LNP (MC3/DOTAP), with 88% organ selectivity. This result once again confirms the potential of CP-LC-0729, while also expanding its application to therapies requiring targeted delivery beyond the liver. Lastly, acknowledging the vast array of possibilities unlocked by the STAAR platform, ongoing studies aim to expand the scope and structures of this platform and explore the delivery mechanisms.</p></section><section id="Sec15"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec16"><h3 class="pmc_sec_title">Materials</h3>
<p id="Par42">All chemical reagents were purchased from Sigma-Aldrich (Burlington, Massachusetts, USA), Tokyo Chemical Industry (TCI, Tokyo, Japan), Fluorochem Ltd (Hadfield, UK) and Ambeed (Arlington Heights, Illinois, USA). 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) were purchased from Avanti Polar Lipids (Alabaster, Alabama, USA). 1,2- dimyristoyl-rac-glycero-3-methoxypolyethylene glycol-2000 (DMG- PEG 2000) was purchased from Cayman Chemicals (Ann Arbor, Michigan, USA). Cholesterol was purchased from Sigma Aldrich (Burlington, Massachusetts, USA). DLin-MC3-DMA (MC3) was purchased from Broadpharm (San Diego, California, USA). DOTAP was purchased from BOC Science (New York, USA).</p></section><section id="Sec17"><h3 class="pmc_sec_title">mRNA synthesis</h3>
<p id="Par43">Firefly luciferase mRNA was synthesized following a previous reported method<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>. mRNA complete sequence is available in Fig. <a href="#MOESM2" class="usa-link">S1</a>.</p></section><section id="Sec18"><h3 class="pmc_sec_title">General method for the synthesis of STAAR ionizable lipids</h3>
<p id="Par44">STAAR lipids were synthesized using a tandem one-pot reaction. First, thiolactone derivatives (0.15 mmol, 1 equiv.) and acrylate (0.15 mmol, 1 equiv.) were dissolved in 300 ul tetrahydrofuran (THF) at RT, followed by the addition of amine (0.15 mmol, 1 equiv.). Two hours later, THF was removed under vacuum and the resulting crudes were used for initial screening. All crudes were characterized by mass spectrometry and their purity was assessed by HPLC coupled with a light scattering detector (ELSD) (Table <a href="#MOESM2" class="usa-link">S1</a>).</p></section><section id="Sec19"><h3 class="pmc_sec_title">Purification and characterization of ionizable lipid A4B2C8 (CP-LC-0729)</h3>
<p id="Par45">To purify the top-performing lipid, namely CP-LC-0729, its crude product was separated using a CombiFlash NextGen 300+ with gradient elution from 100% of dichloromethane to 50% of 80/20/1 DCM/MeOH/ NH<sub>4</sub>OH (aq). CP-LC-0729 was characterized by mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR). MS-QDa: theoretical [M + H]<sup>+</sup> = 740.63, experimental [M + H]<sup>+</sup> = 740.85; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) <em>δ</em>: 6.76 (m, 1H); 6.37 (d, <em>J</em> = 7.9 Hz, 1H); 4.60 (dt, <em>J</em> = 7.1 Hz <em>J</em> = 7.1 Hz, 1H); 3.98 (d, <em>J</em> = 5.8 Hz, 2H); 3.36 (dt, <em>J</em> = 5.7 Hz <em>J</em> = 5.7 Hz, 2H); 2.78 (t, <em>J</em> = 6.8 Hz, 2H); 2.59 (m, 4H); 2.48 (t, <em>J</em> = 5.9 Hz, 2H); 2.28 (s, 6H); 2.06 (m, 2H); 1.96 (m, 1H); 1.58 (m, 3H); 1.41 (m, 2H); 1.25 (m, 44H); 0.87 (m, 12H).</p></section><section id="Sec20"><h3 class="pmc_sec_title">STAAR cationic lipid (+) CP-LC-0729 synthesis</h3>
<p id="Par46">Lipid CP-LC-0729 (149.5 mg, 0.20 mmol) was dissolved in toluene (0.7 ml) under Argon atmosphere. Then, dimethyl sulfate (22.9 ul, 0.24 mmol) was added and 1 h later the solvent was evaporated under reduced pressure. Afterwards, the crude reaction was purified using a CombiFlash NextGen 300+ with gradient elution from 100% of DCM to 40% of MeOH to afford the pure product (70%).</p>
<p id="Par47">MS-QDa: theoretical [M]<sup>+</sup> = 754.66, experimental [M]<sup>+</sup> = 754.84;</p>
<p id="Par48"><sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) <em>δ</em>: 8.38 (m, 1 H); 8.17 (m, 1H); 4.29 (m, 1H); 3.92 (d, <em>J</em> = 5.6 Hz, 2H); 3.49 (m, 2H); 3.33 (m, 2H); 3.09 (s, 9H); 2.68 (m, 2H); 2.60 (m, 2H); 2.41 (m, 1H); 2.19 (m, 1H); 1.80 (m, 2H); 1.57 (m, 1H); 1.48 (m, 2H); 1.36–1.04 (m, 46H); 0.89 (m, 12H).</p>
<section id="Sec21"><h4 class="pmc_sec_title">Nanoparticle formulation</h4>
<section id="FPar1"><h5 class="pmc_sec_title">General procedure</h5>
<p id="Par49">For all LNP formulations, mRNA was dissolved in a pH 4, 10 mM sodium citrate solution and combined with the lipid mixtures, which comprised a combination of STAAR ionizable lipids, DOPE, cholesterol, and DMG-PEG2000, at an N/P ratio of 6. For the specific experiments including a fifth cationic lipid, these lipidic and N/P ratios were modified as detailed in Table <a href="#MOESM2" class="usa-link">S5</a>.</p>
<p id="Par50">In the initial screening process (optimization phases 1 and 2), a direct pipetting mixing method was used whereas a microfluidics equipment was employed for the subsequent phases and for the extrahepatic targeting formulations with the permanently cationic lipids. Hence, briefly, the methods followed in each of these stages is as follows:</p>
<p id="Par51">Direct pipetting mixing (lipid screening phases 1 and 2): the ethanolic lipid phase and the aqueous mRNA solution were mixed at an N/P ratio of 6 (mol/mol) by pipetting the aqueous solution into the organic phase with vigorous pipetting for about 10 s. The resulting LNPs were diluted 1:1 with a pH 8 buffered solution<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>.</p>
<p id="Par52">Microfluidic mixing (fine-tuning of lipid structure and cationic lipid formulations): both the ethanolic lipid phase and the aqueous mRNA solution were mixed using a NanoAssemblr<sup>®</sup> Ignite™ (Precision NanoSystems) device with a flow rate ratio (FRR) of 3:1 and a total flow rate (TFR) of 12 ml/min. The resulting LNPs were dialyzed overnight against a pH 8 Tris buffer solution containing 15% sucrose. The final LNP solution was adjusted to a concentration of 100 µg/ml of mRNA, filtered through a 0.22 µm filter, and stored at 4 °C.</p></section></section></section><section id="Sec22"><h3 class="pmc_sec_title">Characterization</h3>
<p id="Par53"><sup>1</sup>H-RMN were measured using a Bruker 400 MHz NMR spectrometer. HPLC-ELSD-MS was performed on a Waters Alliance equipped with Waters ELSD 2424 and Waters Acquity QDa detectors. The hydrodynamic size, zeta potential and polydispersity index (PDI) physicochemical parameters of LNPs were measured using a Malvern Zetasizer® Advance Lab Blue Label Equipment. CryoTEM analysis, including sample preparation and image collection, was performed using the CIC-bioGUNE Electron Microscopy Platform (Bilbao, Spain). The mRNA encapsulation efficiency and the pKa of LNP were obtained using Quant-IT® Ribogreen following the manufacturer’s instructions and a 6-(p-toluidinyl)naphthalene-2-sulfonic acid (TNS) assay, respectively<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>. Characterization data is available in supporting information.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Animals and cell lines</h3>
<p id="Par54">All animal experiments were conducted in agreement with European and national directives for protection of experimental animals. Experimental procedures were approved by the Ethics Committee for Animal Experiments of University of Zaragoza (PI07/23).</p>
<p id="Par55">Eight to ten weeks old female BALB/cAnNRj mice were purchased from Janvier Labs. All mice were housed and maintained in specific pathogen-free conditions in the facilities of Centro de Investigaciones Biomédicas de Aragón (Zaragoza, Spain; reference ES 50 297 0012 01). Animals underwent a 1-week acclimation period upon arrival at the research facilities. Housing conditions were controlled, maintaining a room temperature of 20–24 °C with 50%–70% humidity, a light intensity of 60 lux and a light-dark cycle of 12 h. Food and water were provided ad libitum.</p>
<p id="Par56">HepG2 cells were obtained from the American Type Culture Collection (ATCC). Cells were cultured on RPMI 1640 (Gibco, 31870074), supplemented with 10% Fetal Bovine Serum (Sigma, F7524), 1% Penicillin-Streptomycin Solution (Gibco, 15140122) and 2 mM Glutamax (Fisher, 35050038).</p></section><section id="Sec24"><h3 class="pmc_sec_title">Cellular internalization inhibition</h3>
<p id="Par57">HepG2 cells were seeded in Delta-treated 96-well plates at a density of 10,000 cells/well in complete DMEM and incubated overnight at 37 °C and 5% CO<sub>2</sub>. Then, cells were pre-treated for 1 h with endocytosis inhibitors: amiloride (1 mM), chlorpromazine (15 µM), genistein (150 µM) and methyl-B-cyclodextrin (1.25 mM). After the inhibition treatment, cells were transfected with LNPs encapsulating luciferase mRNA (200 ng mRNA/well) and formulated with the different ionizable lipids. After 4 h incubation the cell medium was replaced with fresh complete DMEM and incubated overnight. Cells were lysed with PBS-Triton 0.1%, cell lysate was transferred to an opaque 96-well white plate and d-Luciferin (GoldBio LUCK-100 resuspended in 100 mM Tris-HCl pH 7.8, 5 mM MgCl<sub>2</sub>, 250 μM CoA, 150 μM ATP buffer) was added to each well reaching a final concentration of 150 μg/mL. Luminescence was measured after 5 min of incubation at room temperature in a FLUOstar Omega plate reader (BMG Labtech). The efficiency of endocytosis was subsequently evaluated comparing luminescence signal of the untreated wells, and the wells treated with each inhibitor for each LNP.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Hemolysis assay</h3>
<p id="Par58">Erythrocytes were isolated from fresh heparinized human blood sample. A volume of 2 mL of blood was washed three times with neutral PBS (pH 7.4) by centrifugation at 800 × <em>g</em> for 5 min. Afterwards, the sample was resuspended in a total volume of 1 mL either in neutral or acid PBS (pH 6). Isolated erythrocytes were diluted one hundred times in PBS with the corresponding pH. Erythrocytes were incubated with LNPs at a final mRNA concentration of 2.5 ug/ml at 37 °C for 1 h. Finally, the erythrocytes were centrifuged at 800 × <em>g</em> for 5 min and 60 μl of the supernatant was transferred to a 96-well plate. 0.1% Triton X-100 was included as a positive control for membrane disruption. Absorbance was measured at 540 nm in a FLUOstar Omega plate reader (BMG Labtech)<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>.</p></section><section id="Sec26"><h3 class="pmc_sec_title">In vivo safety evaluation</h3>
<p id="Par59">Animals were inoculated intravenously with 2.5 mg/kg of luciferase-encoding mRNA formulated in the indicated LNPs as described above. Throughout the experiment, mice were periodically weighed and monitored for observable clinical signs of toxicity.</p>
<p id="Par60">Blood samples were collected from the submandibular vein on days 1 and 2 post-inoculation and serum samples were obtained for biochemical analysis. Samples were centrifuged at 8000 rcf at 4 °C for 10 min and supernatants were collected. Biochemical analyses were performed using Cobas c-311 (Roche Diagnostics) according to manufacturer instructions.</p></section><section id="Sec27"><h3 class="pmc_sec_title">In vivo imaging</h3>
<p id="Par61">For intramuscular inoculation, animals were injected with 0.05 mg/kg of the indicated Luciferase-encoding mRNA-LNPs into the right thigh muscle. LNPs were diluted in Tris buffer containing 15% sucrose in a final volume of 30 µL, and administered using a 30G insulin syringe.</p>
<p id="Par62">For intravenous inoculation, animals were injected into the tail vein with 0.2 mg/kg of the indicated Luciferase-encoding mRNA-LNPs. LNPs were diluted in Tris buffer containing 15% sucrose in a final volume of 250 µL and administered using a 27G needle.</p>
<p id="Par63">At 4 h post-inoculation, mice were anesthetized by inhalation of Isoflurane (IsoVet) 4% using an animal inhalation chamber. The maintenance of the anesthesia was sustained at 1.5% isoflurane. D-luciferin (12507, Quimigen) was intraperitoneally injected at 150 mg/kg diluted in PBS. Luminescence images were acquired 20 min after luciferin inoculation.</p>
<p id="Par64">For ex vivo luminescence studies, mice were euthanized 20 min after luciferin injection and liver, spleen, lungs, heart, kidneys and intestine were aseptically removed.</p>
<p id="Par65">In vivo and ex vivo luminescence images as well as fluorescence images of DiR-labeled LNPs were acquired using the IVIS Lumina XRMS Imaging System, following manufacturer’s instructions.</p></section><section id="Sec28"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par66">Data are presented as mean ± SD or mean. Student’s <em>t</em> test, one-way or two-way analysis of variance (ANOVA) followed by Tukey test was applied for comparison between two groups or among multiple groups using GraphPad Prism 10.0, respectively.</p></section><section id="Sec29"><h3 class="pmc_sec_title">Reporting summary</h3>
<p id="Par67">Further information on research design is available in the <a href="#MOESM3" class="usa-link">Nature Portfolio Reporting Summary</a> linked to this article.</p></section></section><section id="Sec30"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12000586/bin/42004_2025_1516_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Transparent Peer Review file</a><sup> (838.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12000586/bin/42004_2025_1516_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (2MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12000586/bin/42004_2025_1516_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (70.8KB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors would like to acknowledge the use of Servicios Científico Técnicos del CIBA (IACS-Universidad de Zaragoza) and Servicio de análisis bioquímicos de CIMA (Universidad de Navarra). The authors would like to extend their sincere gratitude to all the members of Certest Pharma group as well as Dr. Irene Maluenda-Borderas. Their valuable insights and expertise significantly contributed to the success of this research. A.P. is funded by DIN2021-011799 financed by the Ministerio de Ciencia e Innovación MCIN/AEI / 10.13039/501100011033. This study was supported by Gobierno de Aragón (Spain) through project IDMF/2021/0009 (Nuevas tecnologías para el diseño y obtención de vacunas de ARN en Aragón).</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization: A.P., J.H., J.G.W., and J.M.O.; Lipid molecular design and synthetic methodology: J.H., A.P., and J.G.W.; Lipid synthesis and characterization experiments: A.P., J.H., and B.B.; LNP formulation and characterization: A.T., T.A., and D.D.M.; mRNA synthesis: D.C.; Biological and biochemical assays: A.L., A.G.L., and E.M.; Supervision: J.G.W., J.M.O., and E.P.H.; Writing the original draft: J.H., A.P., and J.G.W.; Manuscript review: all authors.</p></section><section id="notes2"><h2 class="pmc_sec_title">Peer review</h2>
<section id="FPar2"><h3 class="pmc_sec_title">Peer review information</h3>
<p id="Par68"><em>Communications Chemistry</em> thanks Yusuke Sato and the other, anonymous, reviewers for their contribution to the peer review of this work. Peer review reports are available.</p></section></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files.</p></section><section id="FPar3"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par69">The authors declare the following competing financial interest(s): A.P., J.H., D.D.M., A.T., J.M.O. and J.G.W. are inventors on a patent related to this publication (“Ionizable lipids and lipid nanoparticles containing thereof”; WO2024110381). All the authors declare to be employees of Certest Biotec.</p></section><section id="FPar4"><h2 class="pmc_sec_title">Ethical approval</h2>
<p id="Par70">This study was conducted following established ethical guidelines, in accordance with European and national directives for protection of experimental animals, and approved by the Ethics Committee for Animal Experiments of University of Zaragoza (PI07/23). Our research team reflects a commitment to diversity and inclusion, with efforts made to support equal opportunities in scientific collaboration and authorship.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
<div class="fn p" id="fn2"><p>These authors contributed equally: Álvaro Peña, Juan Heredero.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Juan Martínez-Oliván, Email: jmartinez@certest.es.</p>
<p>Javier Giménez-Warren, Email: jgimenez@certest.es.</p></section><section id="sec32"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s42004-025-01516-z.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Qin, S. et al. mRNA-based therapeutics: powerful and versatile tools to combat diseases. <em>Signal Transduct. Target. Ther.</em><strong>7</strong>, 166 (2022).
</cite> [<a href="https://doi.org/10.1038/s41392-022-01007-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9123296/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35597779/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qin,%20S.%20et%20al.%20mRNA-based%20therapeutics:%20powerful%20and%20versatile%20tools%20to%20combat%20diseases.%20Signal%20Transduct.%20Target.%20Ther.7,%20166%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Barbier, A. J., Jiang, A. Y., Zhang, P., Wooster, R. &amp; Anderson, D. G. The clinical progress of mRNA vaccines and immunotherapies. <em>Nat. Biotechnol.</em><strong>40</strong>, 840–854 (2022).
</cite> [<a href="https://doi.org/10.1038/s41587-022-01294-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35534554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Barbier,%20A.%20J.,%20Jiang,%20A.%20Y.,%20Zhang,%20P.,%20Wooster,%20R.%20&amp;%20Anderson,%20D.%20G.%20The%20clinical%20progress%20of%20mRNA%20vaccines%20and%20immunotherapies.%20Nat.%20Biotechnol.40,%20840%E2%80%93854%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Tenchov, R., Bird, R., Curtze, A. E. &amp; Zhou, Q. Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. <em>ACS Nano</em><strong>15</strong>, 16982–17015 (2021).
</cite> [<a href="https://doi.org/10.1021/acsnano.1c04996" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34181394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tenchov,%20R.,%20Bird,%20R.,%20Curtze,%20A.%20E.%20&amp;%20Zhou,%20Q.%20Lipid%20nanoparticles%20from%20liposomes%20to%20mRNA%20vaccine%20delivery,%20a%20landscape%20of%20research%20diversity%20and%20advancement.%20ACS%20Nano15,%2016982%E2%80%9317015%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Rohner, E., Yang, R., Foo, K. S., Goedel, A. &amp; Chien, K. R. Unlocking the promise of mRNA therapeutics. <em>Nat. Biotechnol.</em><strong>40</strong>, 1586–1600 (2022).
</cite> [<a href="https://doi.org/10.1038/s41587-022-01491-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36329321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rohner,%20E.,%20Yang,%20R.,%20Foo,%20K.%20S.,%20Goedel,%20A.%20&amp;%20Chien,%20K.%20R.%20Unlocking%20the%20promise%20of%20mRNA%20therapeutics.%20Nat.%20Biotechnol.40,%201586%E2%80%931600%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Hamilton, A. G., Swingle, K. L. &amp; Mitchell, M. J. Biotechnology: overcoming biological barriers to nucleic acid delivery using lipid nanoparticles. <em>PLoS Biol.</em><strong>21</strong>, e3002105 (2023).
</cite> [<a href="https://doi.org/10.1371/journal.pbio.3002105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10231943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37093850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hamilton,%20A.%20G.,%20Swingle,%20K.%20L.%20&amp;%20Mitchell,%20M.%20J.%20Biotechnology:%20overcoming%20biological%20barriers%20to%20nucleic%20acid%20delivery%20using%20lipid%20nanoparticles.%20PLoS%20Biol.21,%20e3002105%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Zhang, Y., Zhang, X., Gao, Y. &amp; Liu, S. Principles of lipid nanoparticle design for mRNA delivery. <em>BMEMat</em><strong>4</strong>, e12116 (2024).</cite> [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20Y.,%20Zhang,%20X.,%20Gao,%20Y.%20&amp;%20Liu,%20S.%20Principles%20of%20lipid%20nanoparticle%20design%20for%20mRNA%20delivery.%20BMEMat4,%20e12116%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ma, Y., Li, S., Lin, X. &amp; Chen, Y. A perspective of lipid nanoparticles for RNA delivery. <em>Exploration</em><strong>4</strong>, 20230147 (2024).
</cite> [<a href="https://doi.org/10.1002/EXP.20230147" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11655307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39713203/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma,%20Y.,%20Li,%20S.,%20Lin,%20X.%20&amp;%20Chen,%20Y.%20A%20perspective%20of%20lipid%20nanoparticles%20for%20RNA%20delivery.%20Exploration4,%2020230147%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Hou, X., Zaks, T., Langer, R. &amp; Dong, Y. Lipid nanoparticles for mRNA delivery. <em>Nat. Rev. Mater.</em><strong>6</strong>, 1078–1094 (2021).
</cite> [<a href="https://doi.org/10.1038/s41578-021-00358-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8353930/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34394960/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hou,%20X.,%20Zaks,%20T.,%20Langer,%20R.%20&amp;%20Dong,%20Y.%20Lipid%20nanoparticles%20for%20mRNA%20delivery.%20Nat.%20Rev.%20Mater.6,%201078%E2%80%931094%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. <em>Nat. Commun.</em><strong>5</strong>, 4277 (2014).
</cite> [<a href="https://doi.org/10.1038/ncomms5277" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4111939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24969323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Whitehead,%20K.%20A.%20et%20al.%20Degradable%20lipid%20nanoparticles%20with%20predictable%20in%20vivo%20siRNA%20delivery%20activity.%20Nat.%20Commun.5,%204277%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Sun, D. &amp; Lu, Z. R. Structure and function of cationic and ionizable lipids for nucleic acid delivery. <em>Pharm. Res.</em><strong>40</strong>, 27–46 (2023).
</cite> [<a href="https://doi.org/10.1007/s11095-022-03460-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9812548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36600047/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sun,%20D.%20&amp;%20Lu,%20Z.%20R.%20Structure%20and%20function%20of%20cationic%20and%20ionizable%20lipids%20for%20nucleic%20acid%20delivery.%20Pharm.%20Res.40,%2027%E2%80%9346%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Han, X. et al. An ionizable lipid toolbox for RNA delivery. <em>Nat. Commun.</em><strong>12</strong>, 1762 (2021).
</cite> [<a href="https://doi.org/10.1038/s41467-021-27493-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8668901/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34903741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han,%20X.%20et%20al.%20An%20ionizable%20lipid%20toolbox%20for%20RNA%20delivery.%20Nat.%20Commun.12,%201762%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Zheng, L. I., Bandara, S. R., Tan, Z. I. &amp; Leal, C. Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm. <em>Proc. Natl. Acad. Sci. USA</em><strong>120</strong>, e2301067120 (2023).
</cite> [<a href="https://doi.org/10.1073/pnas.2301067120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10318962/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37364130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zheng,%20L.%20I.,%20Bandara,%20S.%20R.,%20Tan,%20Z.%20I.%20&amp;%20Leal,%20C.%20Lipid%20nanoparticle%20topology%20regulates%20endosomal%20escape%20and%20delivery%20of%20RNA%20to%20the%20cytoplasm.%20Proc.%20Natl.%20Acad.%20Sci.%20USA120,%20e2301067120%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Dilliard, S. A. &amp; Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. <em>Nat. Rev. Mater.</em><strong>8</strong>, 282–300 (2023).
</cite> [<a href="https://doi.org/10.1038/s41578-022-00529-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9850348/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36691401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dilliard,%20S.%20A.%20&amp;%20Siegwart,%20D.%20J.%20Passive,%20active%20and%20endogenous%20organ-targeted%20lipid%20and%20polymer%20nanoparticles%20for%20delivery%20of%20genetic%20drugs.%20Nat.%20Rev.%20Mater.8,%20282%E2%80%93300%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Chatterjee, S., Kon, E., Sharma, P. &amp; Peer, D. Endosomal escape: a bottleneck for LNP-mediated therapeutics. <em>Proc. Natl Acad. Sci. USA</em><strong>121</strong>, e2307800120 (2024).
</cite> [<a href="https://doi.org/10.1073/pnas.2307800120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10945858/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38437552/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chatterjee,%20S.,%20Kon,%20E.,%20Sharma,%20P.%20&amp;%20Peer,%20D.%20Endosomal%20escape:%20a%20bottleneck%20for%20LNP-mediated%20therapeutics.%20Proc.%20Natl%20Acad.%20Sci.%20USA121,%20e2307800120%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Eygeris, Y., Gupta, M., Kim, J. &amp; Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. <em>Acc. Chem. Res.</em><strong>55</strong>, 2–12 (2022).
</cite> [<a href="https://doi.org/10.1021/acs.accounts.1c00544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34850635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eygeris,%20Y.,%20Gupta,%20M.,%20Kim,%20J.%20&amp;%20Sahay,%20G.%20Chemistry%20of%20lipid%20nanoparticles%20for%20RNA%20delivery.%20Acc.%20Chem.%20Res.55,%202%E2%80%9312%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. <em>Mol. Ther.</em><strong>21</strong>, 1570–1578 (2013).
</cite> [<a href="https://doi.org/10.1038/mt.2013.124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3734658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23799535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maier,%20M.%20A.%20et%20al.%20Biodegradable%20lipids%20enabling%20rapidly%20eliminated%20lipid%20nanoparticles%20for%20systemic%20delivery%20of%20RNAi%20therapeutics.%20Mol.%20Ther.21,%201570%E2%80%931578%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. <em>Nat. Biotechnol.</em><strong>28</strong>, 172–176 (2010).
</cite> [<a href="https://doi.org/10.1038/nbt.1602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20081866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Semple,%20S.%20C.%20et%20al.%20Rational%20design%20of%20cationic%20lipids%20for%20siRNA%20delivery.%20Nat.%20Biotechnol.28,%20172%E2%80%93176%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. &amp; Dong, Y. Lipids and lipid derivatives for RNA delivery. <em>Chem. Rev.</em><strong>121</strong>, 12181–12277 (2021).
</cite> [<a href="https://doi.org/10.1021/acs.chemrev.1c00244" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10088400/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34279087/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang,%20Y.,%20Sun,%20C.,%20Wang,%20C.,%20Jankovic,%20K.%20E.%20&amp;%20Dong,%20Y.%20Lipids%20and%20lipid%20derivatives%20for%20RNA%20delivery.%20Chem.%20Rev.121,%2012181%E2%80%9312277%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. <em>Nat. Biotechnol.</em><strong>37</strong>, 1174–1185 (2019).
</cite> [<a href="https://doi.org/10.1038/s41587-019-0247-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31570898/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Miao,%20L.%20et%20al.%20Delivery%20of%20mRNA%20vaccines%20with%20heterocyclic%20lipids%20increases%20anti-tumor%20efficacy%20by%20STING-mediated%20immune%20cell%20activation.%20Nat.%20Biotechnol.37,%201174%E2%80%931185%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. <em>Nat. Biotechnol.</em><strong>26</strong>, 561–569 (2008).
</cite> [<a href="https://doi.org/10.1038/nbt1402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3014085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18438401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Akinc,%20A.%20et%20al.%20A%20combinatorial%20library%20of%20lipid-like%20materials%20for%20delivery%20of%20RNAi%20therapeutics.%20Nat.%20Biotechnol.26,%20561%E2%80%93569%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Han, X. et al. In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors. <em>Nat. Commun.</em><strong>15</strong>, 1762 (2024).
</cite> [<a href="https://doi.org/10.1038/s41467-024-45537-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10897129/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38409275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han,%20X.%20et%20al.%20In%20situ%20combinatorial%20synthesis%20of%20degradable%20branched%20lipidoids%20for%20systemic%20delivery%20of%20mRNA%20therapeutics%20and%20gene%20editors.%20Nat.%20Commun.15,%201762%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>He, Z. et al. A multidimensional approach to modulating ionizable lipids for high-performing and organ-selective mRNA delivery. <em>Angew. Chem. Int. Ed.</em><strong>62</strong>, e202310401 (2023).</cite> [<a href="https://doi.org/10.1002/anie.202310401" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37661193/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?He,%20Z.%20et%20al.%20A%20multidimensional%20approach%20to%20modulating%20ionizable%20lipids%20for%20high-performing%20and%20organ-selective%20mRNA%20delivery.%20Angew.%20Chem.%20Int.%20Ed.62,%20e202310401%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Sato, Y. et al. Understanding structure-activity relationships of PH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo. <em>J. Control. Release</em><strong>295</strong>, 140–152 (2019).
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2019.01.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30610950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sato,%20Y.%20et%20al.%20Understanding%20structure-activity%20relationships%20of%20PH-sensitive%20cationic%20lipids%20facilitates%20the%20rational%20identification%20of%20promising%20lipid%20nanoparticles%20for%20delivering%20siRNAs%20in%20vivo.%20J.%20Control.%20Release295,%20140%E2%80%93152%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. <em>Nat. Nanotechnol.</em><strong>15</strong>, 313–320 (2020).
</cite> [<a href="https://doi.org/10.1038/s41565-020-0669-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7735425/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32251383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng,%20Q.%20et%20al.%20Selective%20organ%20targeting%20(SORT)%20nanoparticles%20for%20tissue-specific%20mRNA%20delivery%20and%20CRISPR%E2%80%93Cas%20gene%20editing.%20Nat.%20Nanotechnol.15,%20313%E2%80%93320%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Espeel, P. &amp; Du Prez, F. E. One-pot multi-step reactions based on thiolactone chemistry: a powerful synthetic tool in polymer science. <em>Eur. Polym. J.</em><strong>62</strong>, 247–272 (2015).</cite> [<a href="https://scholar.google.com/scholar_lookup?Espeel,%20P.%20&amp;%20Du%20Prez,%20F.%20E.%20One-pot%20multi-step%20reactions%20based%20on%20thiolactone%20chemistry:%20a%20powerful%20synthetic%20tool%20in%20polymer%20science.%20Eur.%20Polym.%20J.62,%20247%E2%80%93272%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Wang, X. et al. Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. <em>Nat. Protoc.</em><strong>18</strong>, 265–291 (2023).
</cite> [<a href="https://doi.org/10.1038/s41596-022-00755-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9888002/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36316378/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20X.%20et%20al.%20Preparation%20of%20selective%20organ-targeting%20(SORT)%20lipid%20nanoparticles%20(LNPs)%20using%20multiple%20technical%20methods%20for%20tissue-specific%20mRNA%20delivery.%20Nat.%20Protoc.18,%20265%E2%80%93291%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. <em>Int. J. Pharm.</em><strong>601</strong>, 120586 (2021).
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2021.120586" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8032477/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33839230/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schoenmaker,%20L.%20et%20al.%20mRNA-lipid%20nanoparticle%20COVID-19%20vaccines:%20structure%20and%20stability.%20Int.%20J.%20Pharm.601,%20120586%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Paunovska, K. et al. A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation. <em>Nano Lett.</em><strong>18</strong>, 2148–2157 (2018).
</cite> [<a href="https://doi.org/10.1021/acs.nanolett.8b00432" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6054134/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29489381/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Paunovska,%20K.%20et%20al.%20A%20direct%20comparison%20of%20in%20vitro%20and%20in%20vivo%20nucleic%20acid%20delivery%20mediated%20by%20hundreds%20of%20nanoparticles%20reveals%20a%20weak%20correlation.%20Nano%20Lett.18,%202148%E2%80%932157%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. <em>Angew. Chem. Int. Ed.</em><strong>51</strong>, 8529–8533 (2012).</cite> [<a href="https://doi.org/10.1002/anie.201203263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3470698/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22782619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jayaraman,%20M.%20et%20al.%20Maximizing%20the%20potency%20of%20siRNA%20lipid%20nanoparticles%20for%20hepatic%20gene%20silencing%20in%20vivo.%20Angew.%20Chem.%20Int.%20Ed.51,%208529%E2%80%938533%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Hashiba, K. et al. Branching ionizable lipids can enhance the stability, fusogenicity, and functional delivery of mRNA. <em>Small Sci.</em><strong>3</strong>, 2200071 (2023).
</cite> [<a href="https://doi.org/10.1002/smsc.202200071" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11935957/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40212983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hashiba,%20K.%20et%20al.%20Branching%20ionizable%20lipids%20can%20enhance%20the%20stability,%20fusogenicity,%20and%20functional%20delivery%20of%20mRNA.%20Small%20Sci.3,%202200071%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Sabnis, S. et al. A novel amino lipid series for MRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. <em>Mol. Ther.</em><strong>26</strong>, 1509–1519 (2018).
</cite> [<a href="https://doi.org/10.1016/j.ymthe.2018.03.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5986714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29653760/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sabnis,%20S.%20et%20al.%20A%20novel%20amino%20lipid%20series%20for%20MRNA%20delivery:%20improved%20endosomal%20escape%20and%20sustained%20pharmacology%20and%20safety%20in%20non-human%20primates.%20Mol.%20Ther.26,%201509%E2%80%931519%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Pardi, N. et al. Expression kinetics of nucleoside-modified MRNA delivered in lipid nanoparticles to mice by various routes. <em>J. Control. Release</em><strong>217</strong>, 345–351 (2015).
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2015.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4624045/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26264835/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pardi,%20N.%20et%20al.%20Expression%20kinetics%20of%20nucleoside-modified%20MRNA%20delivered%20in%20lipid%20nanoparticles%20to%20mice%20by%20various%20routes.%20J.%20Control.%20Release217,%20345%E2%80%93351%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Cornebise, M. et al. Discovery of a novel amino lipid that improves lipid nanoparticle performance through specific interactions with mRNA. <em>Adv. Funct. Mater.</em><strong>32</strong>, 206727 (2022).</cite> [<a href="https://scholar.google.com/scholar_lookup?Cornebise,%20M.%20et%20al.%20Discovery%20of%20a%20novel%20amino%20lipid%20that%20improves%20lipid%20nanoparticle%20performance%20through%20specific%20interactions%20with%20mRNA.%20Adv.%20Funct.%20Mater.32,%20206727%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Ni, H. et al. Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo. <em>Nat. Commun.</em><strong>13</strong>, 4766 (2022).
</cite> [<a href="https://doi.org/10.1038/s41467-022-32281-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9376583/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35970837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ni,%20H.%20et%20al.%20Piperazine-derived%20lipid%20nanoparticles%20deliver%20mRNA%20to%20immune%20cells%20in%20vivo.%20Nat.%20Commun.13,%204766%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. <em>Proc. Natl. Acad. Sci. USA</em><strong>119</strong>, e2116271119 (2022).
</cite> [<a href="https://doi.org/10.1073/pnas.2116271119" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8872770/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35173043/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu,%20M.%20et%20al.%20Lung-selective%20mRNA%20delivery%20of%20synthetic%20lipid%20nanoparticles%20for%20the%20treatment%20of%20pulmonary%20lymphangioleiomyomatosis.%20Proc.%20Natl.%20Acad.%20Sci.%20USA119,%20e2116271119%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Sahoo, D. et al. The constitutional isomerism of one-component ionizable amphiphilic Janus dendrimers orchestrates the total and targeted activities of mRNA delivery. <em>J. Am. Chem. Soc.</em><strong>146</strong>, 3627–3634 (2024).
</cite> [<a href="https://doi.org/10.1021/jacs.3c13569" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38306714/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sahoo,%20D.%20et%20al.%20The%20constitutional%20isomerism%20of%20one-component%20ionizable%20amphiphilic%20Janus%20dendrimers%20orchestrates%20the%20total%20and%20targeted%20activities%20of%20mRNA%20delivery.%20J.%20Am.%20Chem.%20Soc.146,%203627%E2%80%933634%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Cheng, M. H. Y. et al. Induction of Bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency. <em>Adv. Mater.</em><strong>35</strong>, 2303370 (2023).</cite> [<a href="https://doi.org/10.1002/adma.202303370" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37172950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng,%20M.%20H.%20Y.%20et%20al.%20Induction%20of%20Bleb%20structures%20in%20lipid%20nanoparticle%20formulations%20of%20mRNA%20leads%20to%20improved%20transfection%20potency.%20Adv.%20Mater.35,%202303370%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Liu, S. et al. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR–Cas gene editing. <em>Nat. Mater.</em><strong>20</strong>, 701–710 (2021).
</cite> [<a href="https://doi.org/10.1038/s41563-020-00886-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8188687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33542471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20S.%20et%20al.%20Membrane-destabilizing%20ionizable%20phospholipids%20for%20organ-selective%20mRNA%20delivery%20and%20CRISPR%E2%80%93Cas%20gene%20editing.%20Nat.%20Mater.20,%20701%E2%80%93710%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Álvarez-Benedicto, E. et al. Spleen SORT LNP generated in situ CAR T cells extend survival in a mouse model of lymphoreplete B cell lymphoma. <em>Angew. Chem. Int. Ed.</em><strong>62</strong>, e202310395 (2023).</cite> [<a href="https://doi.org/10.1002/anie.202310395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10826899/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37651468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?%C3%81lvarez-Benedicto,%20E.%20et%20al.%20Spleen%20SORT%20LNP%20generated%20in%20situ%20CAR%20T%20cells%20extend%20survival%20in%20a%20mouse%20model%20of%20lymphoreplete%20B%20cell%20lymphoma.%20Angew.%20Chem.%20Int.%20Ed.62,%20e202310395%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Dilliard, S. A. et al. The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles. <em>J. Control. Release</em><strong>361</strong>, 361–372 (2023).
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2023.07.058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10826900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37536547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dilliard,%20S.%20A.%20et%20al.%20The%20interplay%20of%20quaternary%20ammonium%20lipid%20structure%20and%20protein%20corona%20on%20lung-specific%20mRNA%20delivery%20by%20selective%20organ%20targeting%20(SORT)%20nanoparticles.%20J.%20Control.%20Release361,%20361%E2%80%93372%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Martínez, J., Lampaya, V., Larraga, A., Magallón, H. &amp; Casabona, D. Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction. <em>Front. Mol. Biosci.</em><strong>10</strong>, 1248511 (2023).
</cite> [<a href="https://doi.org/10.3389/fmolb.2023.1248511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10570549/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37842641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mart%C3%ADnez,%20J.,%20Lampaya,%20V.,%20Larraga,%20A.,%20Magall%C3%B3n,%20H.%20&amp;%20Casabona,%20D.%20Purification%20of%20linearized%20template%20plasmid%20DNA%20decreases%20double-stranded%20RNA%20formation%20during%20IVT%20reaction.%20Front.%20Mol.%20Biosci.10,%201248511%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Hashiba, K. et al. Overcoming thermostability challenges in mRNA–lipid nanoparticle systems with piperidine-based ionizable lipids. <em>Commun. Biol.</em><strong>7</strong>, 556 (2024).
</cite> [<a href="https://doi.org/10.1038/s42003-024-06235-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11087515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38730092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hashiba,%20K.%20et%20al.%20Overcoming%20thermostability%20challenges%20in%20mRNA%E2%80%93lipid%20nanoparticle%20systems%20with%20piperidine-based%20ionizable%20lipids.%20Commun.%20Biol.7,%20556%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Shin, S. Y., Kang, J. H. &amp; Hahm, K. S. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. <em>J. Pept. Res.</em><strong>53</strong>, 82–90 (1999).
</cite> [<a href="https://doi.org/10.1111/j.1399-3011.1999.tb01620.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10195445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shin,%20S.%20Y.,%20Kang,%20J.%20H.%20&amp;%20Hahm,%20K.%20S.%20Structure-antibacterial,%20antitumor%20and%20hemolytic%20activity%20relationships%20of%20cecropin%20A-magainin%202%20and%20cecropin%20A-melittin%20hybrid%20peptides.%20J.%20Pept.%20Res.53,%2082%E2%80%9390%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12000586/bin/42004_2025_1516_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Transparent Peer Review file</a><sup> (838.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12000586/bin/42004_2025_1516_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (2MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12000586/bin/42004_2025_1516_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (70.8KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The authors declare that the data supporting the findings of this study are available within the paper and its Supplementary Information files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Communications Chemistry are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s42004-025-01516-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/42004_2025_Article_1516.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.4 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12000586/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12000586/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000586%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000586/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12000586/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12000586/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40234552/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12000586/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40234552/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12000586/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12000586/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="VZouK89kzs7ntsPSt3cHH6Tz13SyHtQRk5mBk3fwQFk3F2XWrduAcxAHqcLIvYk9">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
